Sheba Beyond’s hybrid high-risk pregnancy unit uses INVU by Nuvo for fetal heart tracing (206 admissions, Oct 2023 to Dec 2025).
Sheba used INVU for the NST in its hybrid gestational-diabetes programme; patients rated INVU 9.4 of 10.
University of Missouri study with INVU as the home-monitoring arm, at three Missouri sites.
Randomized trial at Penn Medicine of remote NSTs with INVU versus office NSTs in high-risk pregnancies.
Sheba Beyond describes how it designed a hybrid hospital-and-home unit for high-risk pregnancy, using INVU by Nuvo for fetal heart tracing at home.
Read the highlight →
Sheba Medical Center ran a hybrid programme for women with gestational diabetes, with INVU for the nonstress test at home.
Read the highlight →
Penn researchers asked patients who did their nonstress tests at home with INVU how it went, through weekly surveys and interviews.
Read the highlight →
A Banner Health clinician wrote to the journal about a year of remote nonstress testing with INVU in rural care.
Read the highlight →
At Penn Medicine, 34 patients with high-risk pregnancies enrolled and 29 did their nonstress tests at home with INVU.
Read the highlight →
An independent review of remote fetal monitoring in the COVID-19 era describes INVU among the new technologies.
Read the highlight →
INVU’s contraction monitoring was tested in 118 women (78 in the validation phase) against the intrauterine pressure catheter, the clinical reference.
Read the highlight →
INVU derives uterine activity from the mother’s heart signals, electrical and acoustic, rather than from a pressure belt.
Read the highlight →
In 147 pregnant women, fetal and maternal heart rates recorded with INVU were compared with standard cardiotocography (CTG).
Read the highlight →More about INVU™ beyond the published research.
Whether you would like to know more about INVU™, explore a research collaboration, or partner with us, we would love to hear from you.
Email info@nuvocares.com ↗